SUBCONTRACT NO. DPSC03-02246
This is a Time and Materials (T&M) subcontract (hereinafter referred to as “Subcontract”) by and between
DynPort Vaccine Company LLC (hereinafter referred to as “DVC”), a Virginia corporation, and AVANT
Immunotherapeutics, Inc. (hereinafter referred to as “Subcontractor”), hereinafter referred to jointly as “the
Whereas, Subcontractor is, by reason of knowledge, education, and/or experience, capable of performing and
desires to perform services for DVC in support of the U.S. Department of Defense Joint Vaccine Acquisition
Program (JVAP) under U.S. Government Contract No. DAMD17-98-C-8024.
In consideration of the promises, mutual covenants, and agreements contained herein, the parties agree as
1. General Terms and Conditions
The general conditions set forth in Attachment A, General Terms and Conditions, are incorporated herein.
2. Scope of Work
Subject to the terms and conditions of this Subcontract, the Subcontractor will furnish the services described in
Attachment B, Statement of Work.
This Subcontract shall be effective for the period July 1, 2002 through June 30, 2003. DVC may immediately
terminate in the event of the Subcontractor’s breach of this Subcontract, or if DVC’s prime contractual support
for the Subcontractor is terminated. DVC reserves the right to extend the term of this Subcontract upon written
notification to, and mutual agreement of, the Subcontractor.
4. Authorized Funding
a. This Subcontract has an not-to-exceed authorized funded value of $334,257.83, in accordance with
Attachment C, Price Schedule. This value represents the maximum amount the Subcontractor is currently
authorized to expend in performance of the work authorized hereunder.
b. Subcontractor shall notify D